|
Neoplasia
Citations 281-290 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
- Artur Gontarewicz, Stefan Balabanov, Gunhild Keller, Riccardo Colombo, Alessio Graziano, Enrico Pesenti, Daniel Benten, Carsten Bokemeyer, Walter Fiedler, Jürgen Moll, and Tim H. Brümmendorf
Blood 2008; 111: 4355-4364.
[Abstract]
[Full text]
[PDF]
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
- Chia-Ling Chen, Chiou-Feng Lin, Wen-Tsan Chang, Wei-Ching Huang, Chiao-Fang Teng, and Yee-Shin Lin
Blood 2008; 111: 4365-4374.
[Abstract]
[Full text]
[PDF]
The small GTPase Ral mediates SDF-1–induced migration of B cells and multiple myeloma cells
- David J. J. de Gorter, Rogier M. Reijmers, Esther A. Beuling, Hildegonda P. H. Naber, Annemieke Kuil, Marie José Kersten, Steven T. Pals, and Marcel Spaargaren
Blood 2008; 111: 3364-3372.
[Abstract]
[Full text]
[PDF]
Interleukin-2, interleukin-12, and interferon- levels and risk of young adult Hodgkin lymphoma
- Wendy Cozen, Parkash S. Gill, Muhammad T. Salam, Alexandra Nieters, Rizwan Masood, Myles G. Cockburn, W. James Gauderman, Otoniel Martínez-Maza, Bharat N. Nathwani, Malcolm C. Pike, David J. Van Den Berg, Ann S. Hamilton, Dennis M. Deapen, and Thomas M. Mack
Blood 2008; 111: 3377-3382.
[Abstract]
[Full text]
[PDF]
A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis
- Francesco Passamonti, Elisa Rumi, Marianna Caramella, Chiara Elena, Luca Arcaini, Emanuela Boveri, Cecilia Del Curto, Daniela Pietra, Laura Vanelli, Paolo Bernasconi, Cristiana Pascutto, Mario Cazzola, Enrica Morra, and Mario Lazzarino
Blood 2008; 111: 3383-3387.
[Abstract]
[Full text]
[PDF]
Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders
- Linda Morris Brown, Gloria Gridley, David Check, and Ola Landgren
Blood 2008; 111: 3388-3394.
[Abstract]
[Full text]
[PDF]
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
- Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody, Angel León, Jordi Esteve, Juan M. Bergua, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, and Miguel A. Sanz
Blood 2008; 111: 3395-3402.
[Abstract]
[Full text]
[PDF]
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy
- Ping Zhou, Raymond L. Comenzo, Adam B. Olshen, Ezio Bonvini, Scott Koenig, Peter G. Maslak, Martin Fleisher, James Hoffman, Suresh Jhanwar, James W. Young, Stephen D. Nimer, and Adam M. Boruchov
Blood 2008; 111: 3403-3406.
[Abstract]
[Full text]
[PDF]
DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL
- Stéphanie Dulucq, Geneviève St-Onge, Vincent Gagné, Marc Ansari, Daniel Sinnett, Damian Labuda, Albert Moghrabi, and Maja Krajinovic
Blood 2008; 111: 3692-3700.
[Abstract]
[Full text]
[PDF]
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor- B pathways in subtypes of diffuse large B-cell lymphoma
- Lloyd T. Lam, George Wright, R. Eric Davis, Georg Lenz, Pedro Farinha, Lenny Dang, John W. Chan, Andreas Rosenwald, Randy D. Gascoyne, and Louis M. Staudt
Blood 2008; 111: 3701-3713.
[Abstract]
[Full text]
[PDF]
|
|
